Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest HPV vaccine Stories

2013-12-05 23:32:00

Keoma Hamer is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession. Garden City, NY (PRWEB) December 05, 2013 NAPW honors Keoma L. Hamer, Founder and President of The KeLaHa Projects Foundation, as 2013/2014 Professional Woman of the Year for leadership with this prestigious distinction. As the largest, most-recognized organization of women in the United States, spanning virtually every industry and profession, the National...

2013-11-26 13:40:27

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics, a JAMA Network publication. HPV vaccine coverage among teenagers has increased since the vaccine was licensed in 2006 but it still remains low compared with other recommended...

2013-11-13 12:27:11

DUBLIN, November 13, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/g422mm/vaccine_market_by) has announced the addition of the "Global Vaccine Market by Technology & Types, Various Classes & Indications 2013-2022" [http://www.researchandmarkets.com/research/g422mm/vaccine_market_by ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global vaccine technology market is...

2013-11-04 14:05:52

A study by Indiana University public health researchers found that the opportunity for significant progress in addressing cervical cancer across the country is being squandered -- not because of a lack of money, but because of a void of leadership and organization at the state levels. "We focus on cervical cancer because it is likely the 'low-hanging fruit' opportunity to beat a cancer in this generation," said Beth Meyerson, a health policy expert at the IU School of Public...

HPV vaccine effective in one dose
2013-11-04 11:44:37

Brett Smith for redOrbit.com - Your Universe Online An HPV vaccine that guards against cervical cancer was shown to be effective in just one dose, instead of the recommended three, according to a new study published by the journal Cancer Prevention Research. The study researchers found that one dose of the vaccine for human papillomavirus (HPV), the disease known to cause cervical cancer, established antibodies that remained stable in the blood for four years. The team said their study was...

2013-10-31 14:39:58

Less than 7% of cervical cancer patients in Kenya are getting the optimum treatment needed to eradicate the disease, leading to unnecessary deaths - a study by The University of Manchester scientists reveals. Results from the research, which looked retrospectively at the treatment of women diagnosed with cervical cancer during a two year period, showed 18% of cervical cancer patients in the East African country died within two years of a diagnosis. Dr Ian Hampson, from The University of...

2013-10-21 23:02:01

Representatives of 10 grantee programs participating in a two-year initiative, “Improving Understanding of Adolescent Vaccination through Innovative Local Public Health Demonstration Projects,” gathered at the Cincinnati Children’s Hospital Medical Center last week to discuss strategies and tactics for increasing adolescent immunization rates for a range of vaccines important for teens and young adults, including human papillomavirus, meningococcal, influenza, and Tdap (tetanus,...

2013-10-21 12:27:58

COLUMBUS, Ohio, Oct. 21, 2013 /PRNewswire/ -- The teenage years are a busy time for young people and parents and are filled with changes of many types - physical, emotional and environmental. Many changes take place over the teen years physically, emotionally and socially. (Logo: http://photos.prnewswire.com/prnh/20130927/CL88116LOGO ) "Whether teens are in middle school or high school, preparing for college or working full-time, they are making the transition into adulthood and...

2013-10-07 09:29:14

Although they are at higher risk for cervical cancer, girls from low-income families are less likely to receive the human papillomavirus (HPV) vaccine that prevents it, and the reasons they are not fully vaccinated differ depending on whether their parents are English-speaking or Spanish-speaking, suggests research being presented at IDWeek 2013™. In the study, Spanish-speaking parents whose daughters were not fully vaccinated said their providers either did not encourage the vaccine or...

2013-10-03 23:28:12

UDoTest has released a DIY home HPV test allowing women to administer the sample collection of cervical cells themselves, ushering in a new era in cervical cancer screening and prevention for South African women. (PRWEB) October 03, 2013 A new cervical cancer screening test looks set to revolutionise the way in which women are tested for this disease. UDoTest has recently released a new self-collection test for HPV, the virus which causes cervical cancer, which has received widespread...


Latest HPV vaccine Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »